Bottom line
FTDZX vs XBI: the short answer
FTDZX (Franklin Biotechnology Discovery Fund) and XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) are both mutual funds.
XBI is cheaper at 0.35% vs 0.76% — a difference of $41 a year per $10,000 invested.
Over five years, FTDZX returned +6.4% a year vs −2.7% for XBI.
Updated Nov 19, 2026
FTDZX vs XBI side by side
| FTDZX | XBI | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | SPDR (State Street) |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.76% | 0.35% |
| Annual cost per $10k | $76 | $35 |
| 10-yr cost on $10k (prospectus) | $954 | $443 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +52.7% | +35.8% |
| 5-yr return (annualized) | +6.4% | −2.7% |
| 10-yr return (annualized) | +7.2% | +5.8% |
| Best quarter | — | +44.4% |
| Worst quarter | — | −26.2% |
| Net assets (fund) | $1.2B | $10.7B |
| Number of holdings | 126 | 161 |
| Portfolio turnover | 38% | 71% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
6 of FTDZX's top 25 holdings also appear in XBI's top 25.
| Holding | FTDZX | XBI |
|---|---|---|
| Revolution Medicines, Inc. | 3.01% | 1.20% |
| Dianthus Therapeutics, Inc. | 2.32% | 1.18% |
| Mirum Pharmaceuticals, Inc. | 1.98% | 1.16% |
| Praxis Precision Medicines, Inc. | 1.91% | 1.29% |
| Oruka Therapeutics, Inc. | 1.86% | 1.38% |
| Cytokinetics, Inc. | 1.24% | 1.18% |
Source: SEC Form N-PORT
FTDZX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
XBI top 10
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Moderna Inc — 1.41%
- Twist Bioscience Corp — 1.41%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Praxis Precision Medicines Inc — 1.29%
- Erasca Inc — 1.27%
- Revolution Medicines Inc — 1.20%
FAQ
What is the difference between FTDZX and XBI?
FTDZX (Franklin Biotechnology Discovery Fund) and XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) are both mutual funds. XBI is cheaper at 0.35% vs 0.76% — a difference of $41 a year per $10,000 invested.
Which is cheaper, FTDZX or XBI?
XBI has the lower expense ratio (0.35%).
Should I own both FTDZX and XBI?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.